Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Avvisati

Showing results (81-90 of 145) with videos related to

Pageof 15
Sort By:
Blood|December 15, 1993
Absence of reverse transcription-polymerase chain reaction detectable residual disease in patients with acute promyelocytic leukemia in long-term remissionD Diverio, P P Pandolfi, A Biondi, et al.
European Journal of Haematology|March 1, 1994
Classification of patients affected by multiple myeloma using a neural network softwareR Bugliosi, M Tribalto, G Avvisati, et al.
European Journal of Haematology|September 1, 1990
Immunological definition of acute promyelocytic leukemia (FAB M3): a study of 39 casesG De Rossi, G Avvisati, S Coluzzi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1997
Etoposide, intermediate-dose cytarabine and carboplatin (VAC): a combination therapy for the blastic phase of chronic myelogenous leukemiaE Montefusco, M C Petti, G Alimena, et al.
British Journal of Haematology|December 1, 1995
Combined cytogenetic, FISH and molecular analysis in acute promyelocytic leukaemia at diagnosis and in complete remissionM Mancini, M Nanni, M Cedrone, et al.
Leukemia Research|March 29, 2011
Sytemic strongyloidiasis and primary aspergillosis of digestive tract in a patient with T-cell acute lymphoblastic leukemiaF Marchesi, D Lepanto, O Annibali, et al.
Leukemia|September 1, 1995
Therapy-related acute myelomonocytic leukemia following successful treatment for acute promyelocytic leukemiaE Todisco, A M Testi, G Avvisati, et al.
Leukemia & Lymphoma|January 1, 1995
Acute myeloid leukemias M2 potentially misdiagnosed as M3 variant French-American-Britain (FAB) subtype: a transitional form?S Fenu, D Carmini, F Mancini, et al.
Haematologica|January 12, 2000
Clinical outcome of extramedullary plasmacytomaP Galieni, M Cavo, A Pulsoni, et al.
Blood|August 15, 1996
AIDA (all-trans retinoic acid + idarubicin) in newly diagnosed acute promyelocytic leukemia: a Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) pilot studyG Avvisati, F Lo Coco, D Diverio, et al.
Pageof 15

Showing results (81-90 of 145) with videos related to

Sort By:
Pageof 15
Blood|December 15, 1993
Absence of reverse transcription-polymerase chain reaction detectable residual disease in patients with acute promyelocytic leukemia in long-term remissionD Diverio, P P Pandolfi, A Biondi, et al.
European Journal of Haematology|March 1, 1994
Classification of patients affected by multiple myeloma using a neural network softwareR Bugliosi, M Tribalto, G Avvisati, et al.
European Journal of Haematology|September 1, 1990
Immunological definition of acute promyelocytic leukemia (FAB M3): a study of 39 casesG De Rossi, G Avvisati, S Coluzzi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1997
Etoposide, intermediate-dose cytarabine and carboplatin (VAC): a combination therapy for the blastic phase of chronic myelogenous leukemiaE Montefusco, M C Petti, G Alimena, et al.
British Journal of Haematology|December 1, 1995
Combined cytogenetic, FISH and molecular analysis in acute promyelocytic leukaemia at diagnosis and in complete remissionM Mancini, M Nanni, M Cedrone, et al.
Leukemia Research|March 29, 2011
Sytemic strongyloidiasis and primary aspergillosis of digestive tract in a patient with T-cell acute lymphoblastic leukemiaF Marchesi, D Lepanto, O Annibali, et al.
Leukemia|September 1, 1995
Therapy-related acute myelomonocytic leukemia following successful treatment for acute promyelocytic leukemiaE Todisco, A M Testi, G Avvisati, et al.
Leukemia & Lymphoma|January 1, 1995
Acute myeloid leukemias M2 potentially misdiagnosed as M3 variant French-American-Britain (FAB) subtype: a transitional form?S Fenu, D Carmini, F Mancini, et al.
Haematologica|January 12, 2000
Clinical outcome of extramedullary plasmacytomaP Galieni, M Cavo, A Pulsoni, et al.
Blood|August 15, 1996
AIDA (all-trans retinoic acid + idarubicin) in newly diagnosed acute promyelocytic leukemia: a Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) pilot studyG Avvisati, F Lo Coco, D Diverio, et al.
Pageof 15